Abstract
Wilms' tumour is common among children but rare in adults. Children with Wilms' tumour have better prognosis even when diagnosed at advanced stage. We report the case of an adolescent girl with chemo-resistant metastatic Wilms' tumour treated previously with two lines of chemotherapy. Upon progression on second line chemotherapy, there was a partial response to Bevacizumab based combination chemotherapy in the third line. Patient was referred for high dose chemotherapy and autologous stem cell therapy. The latter could not be achieved. The patient had a relapse 3 months later and succumbed to the disease.
Original language | English |
---|---|
Pages (from-to) | S71-S72 |
Journal | Journal of the College of Physicians and Surgeons Pakistan |
Volume | 24 |
Publication status | Published - 2014 |
Externally published | Yes |
Keywords
- Adolescent
- Bevacizumab
- Partial response
- Wilms' tumour
ASJC Scopus subject areas
- Medicine(all)